Your browser doesn't support javascript.
loading
Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease.
Mason, Mike J; Schinke, Carolina; Eng, Christine L P; Towfic, Fadi; Gruber, Fred; Dervan, Andrew; White, Brian S; Pratapa, Aditya; Guan, Yuanfang; Chen, Hongjie; Cui, Yi; Li, Bailiang; Yu, Thomas; Chaibub Neto, Elias; Mavrommatis, Konstantinos; Ortiz, Maria; Lyzogubov, Valeriy; Bisht, Kamlesh; Dai, Hongyue Y; Schmitz, Frank; Flynt, Erin; Danziger, Samuel A; Ratushny, Alexander; Dalton, William S; Goldschmidt, Hartmut; Avet-Loiseau, Herve; Samur, Mehmet; Hayete, Boris; Sonneveld, Pieter; Shain, Kenneth H; Munshi, Nikhil; Auclair, Daniel; Hose, Dirk; Morgan, Gareth; Trotter, Matthew; Bassett, Douglas; Goke, Jonathan; Walker, Brian A; Thakurta, Anjan; Guinney, Justin.
Afiliación
  • Mason MJ; Sage Bionetworks, Seattle, WA, USA. michael.mason@sagebase.org.
  • Schinke C; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Eng CLP; Computational & Systems Biology, Genome Institute of Singapore, Singapore, Singapore.
  • Towfic F; Celgene Corporation, Summit, NJ, USA.
  • Gruber F; GNS Healthcare, Cambridge, MA, USA.
  • Dervan A; Celgene, Seattle, WA, USA.
  • White BS; Sage Bionetworks, Seattle, WA, USA.
  • Pratapa A; Department of Computer Science, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA.
  • Guan Y; Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Chen H; Shanghai Jiao Tong University, Shanghai, China.
  • Cui Y; Stanford University School of Medicine, Palo Alto, CA, USA.
  • Li B; Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Yu T; Sage Bionetworks, Seattle, WA, USA.
  • Chaibub Neto E; Sage Bionetworks, Seattle, WA, USA.
  • Mavrommatis K; Celgene Corporation, Summit, NJ, USA.
  • Ortiz M; Predictive Sciences, Celgene Corporation, Seville, Spain.
  • Lyzogubov V; University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Bisht K; Celgene Corporation, Summit, NJ, USA.
  • Dai HY; M2Gen, Tampa, FL, USA.
  • Schmitz F; Celgene, Seattle, WA, USA.
  • Flynt E; Celgene Corporation, Summit, NJ, USA.
  • Dan Rozelle; Rancho BioSciences, San Diego, CA, USA.
  • Danziger SA; Celgene, Seattle, WA, USA.
  • Ratushny A; Celgene, Seattle, WA, USA.
  • Dalton WS; Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
  • Goldschmidt H; Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Avet-Loiseau H; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany.
  • Samur M; Institut Universitaire du Cancer Oncopole, Toulouse, France.
  • Hayete B; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sonneveld P; Department of Biostatistics, Harvard TH Chan School of Public Health, Boston, MA, USA.
  • Shain KH; GNS Healthcare, Cambridge, MA, USA.
  • Munshi N; Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Auclair D; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.
  • Hose D; Tumor Biology Department, Moffitt Cancer Center, Tampa, FL, USA.
  • Morgan G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Trotter M; VA Boston Healthcare System, Boston, MA, USA.
  • Bassett D; Multiple Myeloma Research Foundation, Norwalk, CT, USA.
  • Goke J; Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Walker BA; Labor für Myelomforschung, Universitätsklinikum Heidelberg, Heidelberg, Germany.
  • Thakurta A; University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Guinney J; Predictive Sciences, Celgene Corporation, Seville, Spain.
Leukemia ; 34(7): 1866-1874, 2020 07.
Article en En | MEDLINE | ID: mdl-32060406
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Biomarcadores de Tumor / Regulación Neoplásica de la Expresión Génica / Ensayos Clínicos como Asunto / Modelos Estadísticos / Epigénesis Genética / Proteínas de Unión al ADN / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Biomarcadores de Tumor / Regulación Neoplásica de la Expresión Génica / Ensayos Clínicos como Asunto / Modelos Estadísticos / Epigénesis Genética / Proteínas de Unión al ADN / Mieloma Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos